A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
French attorney Christophe Jensen turns African American Tia Edwards’ life upside down. She is happier than she’s ever been, but complications arise when Christophe is summoned back to France. Suddenly, the best time of Tia’s life starts falling apart, as she’s forced to choose between her family or her future with a man whose home is in another country. Learn more about this book: http://bit.ly/9ImVi1 Learn more about this author: http://www.karenwhiteowens.com
Australians are closely linked to the sea through commerce, defence, exploration, adventure, sport and play. Our oceans and waterways have influenced our development...and who we are.
The museum captures these themes with fascinating artefact\\\\\\\'s, lively exhibitions, fun activities and even the chance to board ships and experience life on the water.
This summer, experience AQUA: A Journey into the World of Water, a multisensory experience for the whole family. created by ONE DROP, an initiative of Guy Lailberté, Founder of Cirque du Soleil®. http://www.onedrop.org/en/default.aspx
Only in Australia at the Australian National Maritime Museum, Darling Harbour Sydney from 3 December 2011 - 26 February 2012.
http://www.anmm.gov.au/aqua
This summer, join us on Facebook for the chance to WIN great prizes.
http://www.facebook.com/anmmuseum
Walden University Scholars of Change focus on the future, whether they are transforming the way children learn, mentoring, or improving living conditions for others. More than 175 Walden University students and alumni submitted inspiring videos of social change in their communities for the university’s 2014 Scholars of Change video contest. These scholars–along with hundreds of their fellow video contributors–are supporting Walden’s mission by putting their knowledge to use for the greater good.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7388451-walden-university-scholars-of-change/
Children International’s 2013 Youth Report is available beginning today, International Youth Day. The report explains how Children International’s youth programs, with community centers at the core, measurably change outcomes for impoverished youth. The majority of the world’s 1.7 billion young people ages 10 to 24 live in developing countries – many in extreme poverty where they routinely confront threats to their personal safety and progress. Without positive intervention like Children International’s successful youth programs, these at-risk youth can remain trapped in an intergenerational cycle of poverty.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/57997-children-international-2013-youth-report-results-now-available
"Spend less time on paperwork and more time on care. Upgrade your workflow with MTS’s medical transcription services that deliver fast, accurate records, keeping your team productive and patients happy.
#MedicalTranscription #WorkflowEfficiency #HealthcareOperations"
"Spend less time on paperwork and more time on care. Upgrade your workflow with MTS’s medical transcription services that deliver fast, accurate records, keeping your team productive and patients happy.
#MedicalTranscription #WorkflowEfficiency #HealthcareOperations"
In partnership with Men’s Health Network (MHN), Prostate Health Education Network (PHEN), ZERO – the End of Prostate Cancer and Joe Torre, four-time world champion baseball Hall-of-Famer and prostate cancer survivor, Genomic Health, Inc. (Nasdaq: GHDX) today launched Your Prostate Your Decision to educate prostate cancer patients and their loved ones that every man is different and every cancer is unique, and a genomic test can clarify the aggressiveness of one’s disease prior to invasive treatment. This first-of-its-kind national effort aims to address concerning results of a large national survey that found low general awareness about prostate cancer aggressiveness and treatment options, underscoring the need for better understanding of active surveillance as a treatment plan.
“For a man with prostate cancer, a single decision can change his entire life,” said Mr. Torre, reflecting on his own experience with prostate cancer. “When I was diagnosed with prostate cancer, I faced a game-changing decision. While I chose surgery, a less aggressive approach called active surveillance might be the best choice.”
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322251-your-prostate-your-decision-joe-torre-talks-about-prostate-cancer-genomic-testing-treatment-options-psa/
The dance world gets turned upside down as young professional dancers are teamed up with one of their parents to compete for 100,000 dollars in cash and prizes. Premieres Friday Feb 29th at 9pm EST on Lifetime.
The dance world gets turned upside down as young professional dancers are teamed up with one of their parents as they compete for 100000 dollars in cash and prizes. Premieres Friday Feb 29th at 9pm EST on Lifetime.
LifeProof, the award-winning maker of all-protective, everyday cases for smartphones and tablets, today announced the availability of the LifeProof nüüd case for iPad for $129.99 along with new accessories: Shoulder and Hand Straps for $34.99 and the LifeJacket for iPad for $59.99. Unleashing new freedom for mobile computing, the LifeProof nüüd case for iPad is water proof, dirt proof, snow proof and shock proof, and features a totally naked screen that provides a perfect tactile response and visual clarity. The LifeProof iPad case protects both iPad 2 and iPad Gen 3 devices.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58783-lifeproof-nuud-case-for-ipad
